Search Within

ULCERATIVE COLITIS AND CROHN'S DISEASE

Novel MicroRNA Signature to Differentiate Ulcerative Colitis from Crohn Disease: A Genome-Wide Study Using Next Generation Sequencing

Journal: MicroRNA
Volume: 5, Issue: 3
Page: 222-229
Authors: Jingmei Lin, Xinjun Zhang, Zijin Zhao, Noah C. Welker, Yong Li, Yunlong Liu and Mary P. Bronner

Differential Expression of miR-31 between Inflammatory Bowel Disease and Microscopic Colitis

Journal: MicroRNA
Volume: 3, Issue: 3
Page: 155-159
Authors: Chen Zhang, Zijin Zhao, Hany Osman, Rao Watson, ILKe Nalbantoglu and Jingmei Lin

The Therapeutic Impact of Manipulating Microbiota in Inflammatory Bowel Disease

Journal: Current Pharmaceutical Design
Volume: 15, Issue: 18
Page: 2074-2086
Authors: Osamu Kanauchi, Keiichi Mitsuyama and Akira Andoh

Cytokines, Inflammation and Colon Cancer

Journal: Current Cancer Drug Targets
Volume: 11, Issue: 4
Page: 451-464
Authors: L. Klampfer

Potassium Channel Openers and Improvement of Toxic Stress: Do they have Role in the Management of Inflammatory Bowel Disease?

Journal: Inflammation & Allergy - Drug Targets (Discontinued)
Volume: 7, Issue: 3
Page: 129-135
Authors: Azadeh Hosseini-Tabatabaei and Mohammad Abdollahi

Current Concepts on the Genetics and Pharmacogenetics of Inflammatory Bowel Disease: Do they Help in Clinical Management?

Journal: Current Genomics
Volume: 7, Issue: 3
Page: 149-162
Authors: Peter Laszlo Lakatos and Laszlo Lakatos

Commonalities and Differences Between Crohns Disease and Ulcerative Colitis: The Genetic Clues to their Interpretation

Journal: Inflammation & Allergy - Drug Targets (Discontinued)
Volume: 10, Issue: 6
Page: 447-454
Authors: Giovanni C. Actis, Rinaldo Pellicano, Sonia Tarallo and Floriano Rosina

New Pharmacological Perspectives and Therapeutic Potential of PPAR-γ Agonists

Journal: Current Pharmaceutical Design
Volume: 10, Issue: 28
Page: 3505-3524
Authors: C. Alarcon de la Lastra, S. Sanchez-Fidalgo, I. Villegas and V. Motilva

Macrophages in Inflammatory Bowel Disease

Journal: Current Drug Targets - Inflammation & Allergy
Volume: 2, Issue: 2
Page: 155-160
Authors: Olof Grip, Sabina Janciauskiene and Stefan Lindgren

Immune Abnormalities and Endotoxemia in Patients with Ulcerative Colitis and in Their First Degree Relatives: Attempts at Neutralizing Endotoxin- Mediated Effects

Journal: Current Pharmaceutical Design
Volume: 9, Issue: 24
Page: 1937-1945
Authors: L. Amati, L. Caradonna, G. Leandro, T. Magrone, M. Minenna, G. Faleo, N. M. Pellegrino, E. Jirillo and D. Caccavo

Probiotic Lactobacilli: A New Perspective for the Treatment of Inflammatory Bowel Disease

Journal: Current Pharmaceutical Design
Volume: 9, Issue: 24
Page: 1973-1980
Authors: Giuseppe Famularo, Luciana Mosca, Giovanni Minisola, Vito Trinchieri and Claudio De Simone1

Signaling Molecules: The Pathogenic Role of the IL-6/STAT-3 Trans Signaling Pathway in Intestinal Inflammation and in Colonic Cancer

Journal: Current Drug Targets
Volume: 9, Issue: 5
Page: 369-374
Authors: R. Atreya and M. F. Neurath